Page 4 - Intercure Ltd News Today

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) —

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger NEW YORK, TORONTO, and HERZLIYA,... | June 10, 2023

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba...

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 -- InterCure Ltd. , reports today that, further to the Company’s press release issued on February 1, 2023, where the Company had... | June 10, 2023

InterCure Ltd. (NASDAQ:INCR – Get Rating) saw a large decline in short interest in April. As of April 30th, there was short interest totalling 45,400 shares, a decline of 15.9% from the April 15th total of 54,000 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading […]

NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company") is pleased to announce its

InterCure Ltd. (NASDAQ:INCR – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 45,400 shares, a drop of 15.9% from the April 15th total of 54,000 shares. Based on an average trading volume of 64,000 shares, the days-to-cover […]

NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 -- , the largest and fastest growing medical cannabis company outside of North America, is pleased to announce that its Chairman and... | May 15, 2023

NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 -- InterCure Ltd. today announced that Alexander Rabinovitch, CEO of InterCure, will participate in the Cowen 3rd Annual European Cannabis... | May 15, 2023

Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA(1) of $6 Million ...